JF
NUVB icon

Jump Financial’s Nuvation Bio NUVB Stock Holding History

Jump Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
262,557
+92,957
+55% +$518K 0.02% 876
2025
Q4 		$1.52M Buy
+169,600
New +$1.05M 0.02% 800
2025
Q1 		– Sell
-21,460
Closed -$57.1K – 1882
2024
Q4 		$57.1K Sell
21,460
-12,213
-36% -$31.4K ﹤0.01% 1565
2024
Q3 		$77.1K Buy
+33,673
New +$103K ﹤0.01% 1538
2022
Q2 		– Sell
-124,300
Closed -$654K – 1894
2022
Q1 		$654K Buy
+124,300
New +$698K 0.03% 695

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jump Financial's NUVB Position: Q1 2026 in Review

Jump Financial increased its Nuvation Bio (NUVB) stake by 55% in Q1 2026, buying an estimated $518K and bringing the position to 262,557 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #876.

Jump Financial first reported a position in NUVB in Q1 2022 and has held it in 5 quarters since. The position peaked at $1.52M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Jump Financial held 262,557 shares of Nuvation Bio worth $1.13M as of Q1 2026.
  • Jump Financial bought 92,957 Nuvation Bio shares in Q1 2026, an estimated $518K.
  • Nuvation Bio made up 0.02% of Jump Financial's portfolio in Q1 2026, its #876 holding.
  • Jump Financial first reported a position in Nuvation Bio in Q1 2022 and has held it in 5 quarters since.
  • Jump Financial's Nuvation Bio position peaked at $1.52M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.